Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bar-Shalom, R
Right arrow Articles by Front, D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bar-Shalom, R
Right arrow Articles by Front, D

Radiology, Vol 199, 473-476, Copyright © 1996 by Radiological Society of North America

ARTICLES

Diffuse lung uptake of Ga-67 after treatment of lymphoma: is it of clinical importance?

R Bar-Shalom, O Israel, N Haim, M Leviov, R Epelbaum, A Frenkel, S Ben-Haim, GM Kolodny and D Front
Department of Nuclear Medicine, Rambam Medical Center, Haifa, Israel.

PURPOSE: To determine if diffuse lung uptake (DLU) of gallium-67 at scintigraphy in patients with lymphoma is indicative of lymphomatous involvement of the lungs. MATERIALS AND METHODS: Thirty-eight patients (24 male, 14 female; aged 15-76 years) with DLU were examined. The relation between DLU and lymphoma was investigated. Radiographic and computed tomographic findings and the persistence of Ga-67 uptake were investigated to detect lymphomatous involvement of the lungs. The relations between chemotherapy and radiation therapy, previous lung or heart disease, and DLU were also examined. RESULTS: DLU appeared only during or after chemotherapy. No clinical, radiologic, or follow-up evidence indicated that patients with DLU had active lymphomatous involvement of the lungs. The difference in survival between patients with persistent and patients with transient DLU was not statistically significant. No statistically significant correlation between DLU and any possible inductive factor was indicated at multivariate analysis. CONCLUSION: DLU after treatment does not indicate lymphomatous involvement of the lungs.


This article has been cited by other articles:


Home page
 haematolHome page
P. L. Zinzani, M. Tani, R. Trisolini, S. Fanti, V. Stefoni, M. Alifano, P. Castellucci, G. Musuraca, G. Dalpiaz, L. Alinari, et al.
Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma
Haematologica, June 1, 2007; 92(6): 771 - 777.
[Abstract] [Full Text] [PDF]

Home page
 J. Nucl. Med. Technol.Home page
K. A. Morton, J. Jarboe, and E. M. Burke
Gallium-67 Imaging in Lymphoma: Tricks of the Trade
J. Nucl. Med. Technol., December 1, 2000; 28(4): 221 - 232.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
D. Front, R. Bar-Shalom, M. Mor, N. Haim, R. Epelbaum, A. Frenkel, D. Gaitini, G. M. Kolodny, and O. Israel
Aggressive Non-Hodgkin Lymphoma: Early Prediction of Outcome with 67Ga Scintigraphy1
Radiology, January 1, 2000; 214(1): 253 - 257.
[Abstract] [Full Text]

Home page
 RadiologyHome page
D. Front, R. Bar-Shalom, M. Mor, N. Haim, R. Epelbaum, A. Frenkel, D. Gaitini, G. M. Kolodny, and O. Israel
Hodgkin Disease: Prediction of Outcome with 67Ga Scintigraphy after One Cycle of Chemotherapy
Radiology, February 1, 1999; 210(2): 487 - 491.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1996 by the Radiological Society of North America.